INSMED Inc — Director's Dealing 2023

Jan 12, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2023-01-10

Reporting Person: Wise John Drayton (Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-01-10	Common Stock	S	779	$17.96	Disposed	77272	Direct

Footnotes

F1: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.

F2: This is the weighted average sales price representing 779 shares sold at prices ranging from $17.93 to $17.98 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.